Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.47 |
| ▸ | MAOA | P21397 | 6/20 | 0.46 |
| ▸ | CALML3 | P27482 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SDHA | P31040 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394936 | 0.92 | MAOB (0.44) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3397225 | 0.91 | MAOB (0.45) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3397573 | 0.90 | MAOB (0.47) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3394906 | 0.89 | MAOB (0.45) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3394517 | 0.89 | MAOB (0.43) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3397394 | 0.89 | MAOB (0.45) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3392412 | 0.89 | MAOB (0.43) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3394844 | 0.88 | MAOB (0.44) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3394803 | 0.88 | MAOB (0.44) | MAOBMAOACALML3LMNAPTGS1 | |
| SCHEMBL3390781 | 0.88 | MAOB (0.44) | MAOBMAOACALML3LMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234390-A1 | NOVEL COMPOUND AND THEIR USE | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2010-09-16 | — | — | US | claimed |
| US-20100234390-A1 | NOVEL COMPOUND AND THEIR USE | ORCHID RESEARCH LABORATORIES LIMITED (IN) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234390-A1 | NOVEL COMPOUND AND THEIR USE | HTRA1, PRSS1, PRNP | MAOB 2054/4885MAOA 2174/4885CALML3 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.